CD19 and neoplasm: In contrast, mice treated with CD19‐CAR‐DNTs displayed a significantly reduced lymphoma infiltration with some mononuclear CD19‐CAR‐DNTs infiltration into the tumor sites (Supplementary table 3, Figure 8b).